LEGN241018P60000
- 9.60
- 0.000.00%
Legend Biotech Newsroom
Legend Biotech Analyst Ratings
RBC Capital Maintains Legend Biotech(LEGN.US) With Buy Rating, Maintains Target Price $86
Analysts Are Bullish on These Healthcare Stocks: Entera Bio (ENTX), Legend Biotech (LEGN)
Putting half of his wealth into Chinese concept stocks, 'The Big Short prototype' Michael Burry made a profit this time.
As of June 30th, stocks of Alibaba, baidu, and jd.com together account for about 46% of Burry's entire investment portfolio. Billionaire investor David Tepper previously stated that now is the time to 'buy everything', as Chinese stocks still have a lot of upside potential.
Global stock markets welcome the 'most call morning of the year,' as Goldman Sachs fund flow experts exclaim that this 'china trade' is different from the past.
Goldman Sachs expert Rubner mentioned that FOMO is starting to appear locally in China; in the past 48 hours, he conducted more China-related Zoom calls than all related meetings within this year; short-term traders in Goldman Sachs PB business have been buying Chinese stocks for eight consecutive days, with the net buying amount of Chinese stocks in PB business this Tuesday reaching the second highest level in ten years, almost entirely from long positions.
Express News | The People's Bank of China: We need to speed up the introduction of financial increment policy measures files, and implement and implement each policy measure one by one.
Express News | The Central Financial Office and the China Securities Regulatory Commission jointly issued the "Guiding Opinions on Promoting the Entry of Medium to Long-term Funds into the Market".
Express News | Legend Biotech Corp : JP Morgan Raises Target Price to $80 From $79
Bristol Myers, 2seventy Bio Halt Enrollment in Abecma Late-stage Trial
Chinese concept stocks soared nearly 50% this month, consumer and technology stocks have already quietly started! How long can this round of market trend last?
Looking at the performance ranking of Chinese concept stocks in the middle of this month, the optional consumer, internet plus-related, and brokerage sectors have been rising for multiple days in a row, with the highest increase close to fifty percent. Among American stock investors, there are even "smart money" making precise layouts, what signal does this convey?
Last night, Goldman Sachs' phone lines were jammed! Goldman Sachs answered the five most important questions from customers regarding the explosion of assets in China.
Goldman Sachs indicated that their buy volume in Hong Kong stocks and A-shares is 1.87 times, with buying mainly concentrated in Hong Kong.
Multiply Labs Announces a Collaboration on Automating Cell Therapy Manufacturing With Legend Biotech
Legend Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
Legend Biotech Corporation (LEGN): Among Hedge Funds' Top Biotech Stock Picks
Peering Into Legend Biotech's Recent Short Interest
Legend Biotech Down Over 10%, on Pace for Largest Percent Decrease Since July 2022 -- Data Talk
Express News | Fidelity Greater China Fund reduced its holdings of ICBC, Kweichow Moutai, and TSMC, and cleared its positions in Luxshare Precision, while increasing its holdings of PetroChina.
Matthews Emerging Markets Small Companies Fund Boosts Stake in Legend Biotech Corp
HK stocks surge | Genscript Bio (01548) rose nearly 4%, legend biotech's 'Siddarioncel' has been approved for domestic listing.
Genscript Bio (01548) rose nearly 4%, as of press time, up 3.79%, at HK$12.04, with a turnover of HK$39.6598 million.
Beyond The Numbers: 14 Analysts Discuss Legend Biotech Stock